Haft Nicholas

CIK 00018504041 companyLINCOLNSHIRE, IL

SEC Profile

Transactions

Companies

Filings

CIK

0001850404

Recent Transactions

16 trades

Award
Finch Therapeutics Group, Inc.$FNCH
Stock Option (right to buy)
2023-06-08+10,000→ 10,000 total
Award
Finch Therapeutics Group, Inc.$FNCH
Stock Option (right to buy)
2022-06-13+44,843→ 44,843 total
Purchase
Finch Therapeutics Group, Inc.$FNCH
Common Stock, $0.001 par value per share
2021-12-20$10.18/sh+63,850→ 4,056,907 total
Conversion
Finch Therapeutics Group, Inc.$FNCH
Series D Preferred Stock
2021-03-23−1,150,481→ 0 total
Conversion
Finch Therapeutics Group, Inc.$FNCH
Common Stock
2021-03-23+212,893→ 212,893 total
Purchase
Finch Therapeutics Group, Inc.$FNCH
Common Stock
2021-03-23$17.00/sh+882,351→ 882,351 total
Conversion
Finch Therapeutics Group, Inc.$FNCH
Series B Preferred Stock
2021-03-23−1,064,466→ 0 total
Conversion
Finch Therapeutics Group, Inc.$FNCH
Series C Preferred Stock
2021-03-23−366,093→ 0 total
Conversion
Finch Therapeutics Group, Inc.$FNCH
Common Stock
2021-03-23+172,942→ 172,942 total
Conversion
Finch Therapeutics Group, Inc.$FNCH
Common Stock
2021-03-23+366,093→ 1,430,559 total
Conversion
Finch Therapeutics Group, Inc.$FNCH
Series A Preferred Stock
2021-03-23−172,942→ 0 total
Conversion
Finch Therapeutics Group, Inc.$FNCH
Series A Preferred Stock
2021-03-23−143,831→ 0 total
Conversion
Finch Therapeutics Group, Inc.$FNCH
Common Stock
2021-03-23+143,831→ 143,831 total
Conversion
Finch Therapeutics Group, Inc.$FNCH
Common Stock
2021-03-23+1,064,466→ 1,064,466 total
Conversion
Finch Therapeutics Group, Inc.$FNCH
Common Stock
2021-03-23+1,150,481→ 1,150,481 total
Conversion
Finch Therapeutics Group, Inc.$FNCH
Series C Preferred Stock
2021-03-23−212,893→ 0 total

Companies

Finch Therapeutics Group, Inc.
Director
$FNCH

Recent Filings

Address

ONE OVERLOOK POINT, SUITE 100

LINCOLNSHIRE, IL, 60060

View on SEC.gov